We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
-5.2%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
-$3.89M
(-2.2%)
Cap. Flow
+$11.2M
Cap. Flow
% of AUM
6.35%
Top 10 Holdings %
Top 10 Hldgs %
22.1%
Holding
256
New
24
Increased
39
Reduced
133
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.86M |
| 2 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$3.65M |
| 3 |
TSVT
2seventy bio
TSVT
|
+$3.13M |
| 4 |
uniQure
QURE
|
+$3.1M |
| 5 |
Embecta
EMBC
|
+$2.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AdaptHealth
AHCO
|
+$3.44M |
| 2 |
Elanco Animal Health
ELAN
|
+$2.97M |
| 3 |
Centene
CNC
|
+$2.7M |
| 4 |
iShares MBS ETF
MBB
|
+$2.05M |
| 5 |
Lantheus
LNTH
|
+$1.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.71% |
| 2 | Real Estate | 10.29% |
| 3 | Financials | 3.55% |
| 4 | Technology | 3.29% |
| 5 | Energy | 2.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Aurinia Pharmaceuticals
AUPH
$2.05B
| $389K | 0.22% |
50,000
| – | – |
|
|
DPRO
102
Draganfly
DPRO
$155M
| $385K | 0.22% |
20,000
| – | – |
|
103
iShares Mortgage Real Estate ETF
REM
$559M
| $376K | 0.21% |
+16,846
| New | +$401K |
|
104
VanEck High Yield Muni ETF
HYD
$4.49B
| $343K | 0.19% |
7,000
-2,680
| -28% | -$136K |
|
105
EQT Corp
EQT
$31B
| $338K | 0.19% |
8,320
-1,008
| -11% | -$41.7K |
|
106
Medtronic
MDT
$106B
| $313K | 0.18% |
4,000
| – | – |
|
107
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.08B
| $310K | 0.18% |
13,000
+3,100
| +31% | +$76.5K |
|
108
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.02B
| $303K | 0.17% |
+6,000
| New | +$303K |
|
109
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $284K | 0.16% |
+9,435
| New | +$288K |
|
110
Marathon Petroleum
MPC
$91.3B
| $282K | 0.16% |
1,862
-240
| -11% | -$33.5K |
|
111
ExxonMobil
XOM
$611B
| $281K | 0.16% |
2,390
-314
| -12% | -$34.4K |
|
112
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.6B
| $281K | 0.16% |
3,403
-1,353
| -28% | -$115K |
|
113
Vanguard High Dividend Yield ETF
VYM
$80B
| $278K | 0.16% |
2,694
+997
| +59% | +$107K |
|
114
Aflac
AFL
$63.5B
| $270K | 0.15% |
3,520
-118
| -3% | -$8.76K |
|
|
CTRA
115
DELISTED
Coterra Energy
CTRA
| $263K | 0.15% |
9,731
-1,289
| -12% | -$35.1K |
|
116
Progressive
PGR
$121B
| $262K | 0.15% |
1,880
-73
| -4% | -$9.6K |
|
117
ConocoPhillips
COP
$140B
| $259K | 0.15% |
2,162
-280
| -11% | -$32.5K |
|
118
United Airlines
UAL
$37.5B
| $245K | 0.14% |
5,797
-848
| -13% | -$42.9K |
|
119
Valero Energy
VLO
$91.9B
| $244K | 0.14% |
1,724
-216
| -11% | -$28.3K |
|
|
VALN
120
Valneva
VALN
$511M
| $243K | 0.14% |
+20,590
| New | +$289K |
|
121
Phillips 66
PSX
$82.9B
| $240K | 0.14% |
1,999
-247
| -11% | -$27.7K |
|
122
Amgen
AMGN
$198B
| $239K | 0.14% |
890
-28
| -3% | -$6.99K |
|
|
MRO
123
DELISTED
Marathon Oil Corporation
MRO
| $239K | 0.14% |
8,936
-1,218
| -12% | -$31.5K |
|
124
AutoZone
AZO
$49.7B
| $226K | 0.13% |
89
-4
| -4% | -$10K |
|
125
Globe Life
GL
$14.3B
| $226K | 0.13% |
2,074
-77
| -4% | -$8.6K |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, AlphaCentric Advisors held 256 positions worth $176M, down 2.2% from $180M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
AlphaCentric Advisors deployed $11.2M of net new capital in Q3 2023, opening 24 new positions and adding to 39 existing holdings. Its largest new stake was Revance Therapeutics, Inc.: 190,000 shares worth $2.18M.
By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 60% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was Jazz Pharmaceuticals, an estimated $1.9M trimmed.
- AlphaCentric Advisors's largest Q3 2023 buy was Revance Therapeutics, Inc.: 190,000 shares worth $2.18M.
- AlphaCentric Advisors added most to Walgreens Boots Alliance in Q3 2023, an estimated $3.86M increase.
- AlphaCentric Advisors's biggest Q3 2023 reduction was Jazz Pharmaceuticals, cutting an estimated $1.9M.
- AlphaCentric Advisors fully exited AdaptHealth in Q3 2023, selling an estimated $3.44M.
- AlphaCentric Advisors's ten largest holdings make up 22% of its $176M portfolio in Q3 2023.
- AlphaCentric Advisors opened 24 new positions and closed 21 in Q3 2023.
- AlphaCentric Advisors's portfolio value fell 2.2% quarter-over-quarter to $176M.
Based on AlphaCentric Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.